Tilray Inc (NASDAQ:TLRY)

29.00
Delayed Data
As of Sep 20
 -0.96 / -3.20%
Today’s Change
25.15
Today|||52-Week Range
244.00
-58.89%
Year-to-Date

Today’s Trading

Previous close29.96
Today’s open30.23
Day’s range28.98 - 31.06
Volume1,175,017
Average volume (3 months)1,789,366
Market cap$3.1B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-873.51%
Earnings growth (this year)-53.55%
Earnings growth (next 5 years)--
Revenue growth (last year)+110.00%
P/E ratioNM
Price/Sales135.76
Price/Book14.94

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Pharmaceut...-0.23-0.79%
CRSPCRISPR Therapeutics ...+0.82+1.73%
EBSEmergent BioSolution...-0.99-1.90%
IOVAIovance Biotherapeut...+0.22+1.06%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateNovember 12, 2019
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$43.1M
Annual profit (last year)-$67.7M
Net profit margin-157.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Brendan Kennedy
Executive Vice President-
Operations
Greg Christopher
Corporate headquarters
Nanaimo, British Columbia

Forecasts